Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.

DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...

DexCom Inc (DXCM) reports strong international growth and expanding customer base, while facing margin pressures and US ...